Young breast cancer patients share feelings on fertility risks
NCT ID NCT00062400
First seen Jun 04, 2026 · Last updated Jun 16, 2026 · Updated 2 times
Summary
This study surveyed 385 women aged 35 or younger with early-stage breast cancer to learn how they feel about the risk of losing fertility due to chemotherapy. The goal was to understand their attitudes and help doctors plan treatments that respect their concerns. No treatment was given; it was purely a survey to gather information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Academisch Medisch Centrum at University of Amsterdam
Amsterdam, 1105 AZ, Netherlands
-
Algemeen Ziekenhuis Sint-Augustinus
Wilrijk, 2610, Belgium
-
American University of Beirut Medical Center
Beirut, 113-6044, Lebanon
-
Arnhems Radiotherapeutisch Instituut
Arnhem, 6815 AD, Netherlands
-
Azienda Istituti Ospitalieri
Cremona, 26100, Italy
-
CHU Liege - Domaine Universitaire du Sart Tilman
Liège, B-4000, Belgium
-
Centre Hospitalier Etterbeek Ixelles
Brussels, B-1050, Belgium
-
Centro di Riferimento Oncologico - Aviano
Aviano, 33081, Italy
-
Clinica Alemana
Santiago, 5951, Chile
-
European Institute of Oncology
Milan, 20141, Italy
-
Groote Schuur Hospital
Cape Town, 7925, South Africa
-
Hospital Militar
Santiago, Chile
-
Inselspital Bern
Bern, CH-3010, Switzerland
-
Institut Jules Bordet
Brussels, 1000, Belgium
-
Institute of Oncology and Radiology of Serbia
Belgrade, 11000, Serbia
-
Instituto Nacional de Enfermedades Neoplasicas
Lima, 34, Peru
-
Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
Lisbon, 1099-023 Codex, Portugal
-
Instituto de Radiomedicina
Santiago, 10, Chile
-
Kantonsspital - St. Gallen
Sankt Gallen, CH-9007, Switzerland
-
Klinikum der J.W. Goethe Universitaet
Frankfurt, D-60590, Germany
-
Marmara University Hospital
Istanbul, 81190, Turkey (Türkiye)
-
Medical University of Gdansk
Gdansk, 80-211, Poland
-
Ospedale Alessandro Manzoni
Lecco, 23900, Italy
-
Ospedale Beata Vergine
Mendrisio, CH-6850, Switzerland
-
Universitatsklinikum Heidelberg
Heidelberg, 69115, Germany
-
University Hospital Rebro
Zagreb, 41000, Croatia
-
Western Infirmary
Glasgow, Scotland, G11 6NT, United Kingdom
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.